©The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Jan 21, 2017; 23(3): 560-562
Published online Jan 21, 2017. doi: 10.3748/wjg.v23.i3.560
Published online Jan 21, 2017. doi: 10.3748/wjg.v23.i3.560
Endoscopic ultrasound sedation in the United Kingdom: Is life without propofol tolerable?
Jennifer Anne Campbell, Andrew James Irvine, Andrew Derek Hopper, Department of Gastroenterology, Royal Hallamshire Hospital, Sheffield S10 2JF, United Kingdom
Author contributions: Campbell JA wrote this letter, analysed and interpreted data; Irvine AJ and Hopper AD contributed to conception and design of the study, acquisition of data, and analysis and interpretation of data and approved the final version of the article to be published.
Conflict-of-interest statement: All authors are employed by Sheffield Teaching Hospitals NHS Foundation Trust. No funding was required for this study and there are no competing interests to declare.
Correspondence to: Jennifer A Campbell, Department of Gastroenterology, Royal Hallamshire Hospital, Room P39, Glossop Road, Sheffield S10 2JF, United Kingdom. jennifer.campbell@sth.nhs.uk
Telephone: +44-114-2712353 Fax: +44-114-2712692
Received: October 4, 2016
Peer-review started: October 7, 2016
First decision: November 9, 2016
Revised: November 15, 2016
Accepted: December 2, 2016
Article in press: December 2, 2016
Published online: January 21, 2017
Processing time: 101 Days and 11.4 Hours
Peer-review started: October 7, 2016
First decision: November 9, 2016
Revised: November 15, 2016
Accepted: December 2, 2016
Article in press: December 2, 2016
Published online: January 21, 2017
Processing time: 101 Days and 11.4 Hours
Core Tip
Core tip: Strong evidence exists to support safety and tolerability of non-anaesthesiologist-administered propofol for endoscopic ultrasound (EUS) procedures. United Kingdom guidelines, however, recommend propofol is administered only by anaesthesiologists. Consequently, in the United Kingdom, nearly all EUS procedures are performed with combinations of benzodiazepine and opiate sedation for which little tolerability data exists. This letter shares the experience of a single EUS centre using benzodiazepine and opiate sedation demonstrating it can be safe and the resulting tolerability acceptable.